ARCH Venture Fund X, L.P.'s Net Worth
$0
Estimate Recalculated Nov 1, 2024 04:52AM EST
Who is ARCH Venture Fund X, L.P.?
ARCH Venture Fund X, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Neumora Therapeutics, Inc., Erasca, Inc., Verve Therapeutics, Inc., and Prime Medicine, Inc..
SEC CIK
ARCH Venture Fund X, L.P.'s CIK is 0001757011
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $5.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.39% | 1.82M |
$5.50 | $9,999,995.50 | 35.56M |
Feb 8
| |||
Form 4
| +14,957.26% | 43.75M |
—
|
—
| 44.04M |
Feb 8
| |||
Form 4
| +14,957.26% | 43.75M |
—
|
—
| 44.04M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Erasca, Inc. (ERAS) Snapshot price: $2.86
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 11.06M |
—
|
—
| 11.06M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.51M |
—
|
—
| 2.51M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Medicine, Inc. (PRME) Snapshot price: $3.4303
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.2M |
$6.25 | $20,000,000.00 | 3.2M |
Feb 15
| |||
Form 4
|
∞
| 12.26M |
$17.00 |
—
| 12.26M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neumora Therapeutics, Inc. (NMRA) Snapshot price: $10.46
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +102.76% | 1.88M |
—
|
—
| 3.71M |
Dec 8
| |||
Form 4
| +178.19% | 18.92M |
$17.00 |
—
| 29.55M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||